No, dispensaries do not sell psilocybin mushrooms. A cannabis dispensary license authorizes the sale of cannabis products and nothing else, and psilocybin remains a Schedule I controlled substance under federal law. Even in the two states that have built legal psilocybin frameworks, access runs through supervised sessions at licensed facilities, not through retail storefronts you can walk into and shop.
What a Dispensary License Actually Covers
A cannabis dispensary holds a state license tied to one category of business: selling cannabis and cannabis-derived products. That license comes with testing requirements, inventory tracking, and compliance rules written specifically around cannabis. Carrying any other controlled substance would violate both the license terms and federal law. No state cannabis regulator has authorized dispensaries to stock psilocybin, and a dispensary caught doing so would face license revocation and criminal exposure.
Cannabis and psilocybin sit in entirely different regulatory spaces. Cannabis has legal medical or recreational status in most states, each with its own licensing and distribution infrastructure. Psilocybin has no equivalent retail infrastructure anywhere in the country. Different agencies, different statutes, different rules — even in the rare places where both have some form of legal status.
Psilocybin Is Still a Schedule I Federal Drug
Psilocybin is listed as a Schedule I hallucinogenic substance under the Controlled Substances Act, alongside LSD and MDMA in the most restrictive federal category.1Office of the Law Revision Counsel. 21 USC 812 – Schedules of Controlled Substances The DEA’s regulatory schedule lists psilocybin and psilocyn by name.2eCFR. 21 CFR 1308.11 – Schedule I
Cannabis technically sits in the same schedule on paper, but the federal government has largely declined to enforce cannabis laws in states with legal programs. No similar enforcement pause exists for psilocybin. Federal prosecutors retain full authority to charge psilocybin offenses regardless of any state or city action, and distribution of a Schedule I substance can carry up to 20 years in prison for a first offense, with fines reaching $1 million.3Office of the Law Revision Counsel. 21 USC 841 – Prohibited Acts A Anyone selling mushrooms from a storefront is exposed to distribution-level charges, not simple possession.4Office of the Law Revision Counsel. 21 USC 844 – Penalties for Simple Possession
Decriminalization Is Not Legalization
A number of cities have decriminalized psilocybin in recent years, including Denver, Oakland, Santa Cruz, and Seattle, along with Washington, D.C. and scattered municipalities in other states. Decriminalization is frequently mistaken for legalization, and that confusion is exactly what fuels the assumption that mushrooms must be available at a shop somewhere.
Decriminalization means local law enforcement treats psilocybin possession as a low priority. Police are directed to focus elsewhere, and local prosecutors may decline to charge possession cases. It does not make psilocybin legal. It does not create a licensing framework. It does not authorize anyone to sell, distribute, or manufacture psilocybin. And it provides no protection against federal enforcement. A person in a decriminalized city who buys mushrooms from a storefront is still committing a federal crime, and the seller is committing a more serious one.
Washington, D.C. shows the gap clearly. After voters approved a decriminalization initiative, dozens of storefronts opened selling psilocybin products openly. Authorities shut down nearly 60 of these shops, arresting operators and charging them with distribution of a controlled substance. Decriminalization of personal possession did nothing to shield commercial sellers.
Where Legal Psilocybin Access Does Exist
Only two states have built legal psilocybin frameworks, and neither resembles a dispensary. Both require supervised consumption at a licensed facility with a trained facilitator present. You cannot buy psilocybin and take it home.
Oregon
Oregon launched the first legal psilocybin program in the country under its Psilocybin Services Act. Clients purchase and consume psilocybin products on-site at a licensed service center under the direct supervision of a licensed facilitator. Taking any psilocybin product off the premises is prohibited. No prescription or medical referral is required, but clients must be at least 21 and must complete a preparation session with their facilitator before the administration session. Facilitators graduate from state-approved training programs and pass background checks.
Colorado
Colorado voters approved Proposition 122 in 2022, creating a regulated natural medicine program. Like Oregon, Colorado’s model centers on supervised use at licensed “healing centers” where participants consume psilocybin during administration sessions with a facilitator present. The state explicitly prohibits giving away psilocybin as part of a business promotion or commercial activity, closing the gifting loophole storefronts elsewhere have tried to exploit.
Colorado’s law also permits personal use by adults 21 and older, including possession, cultivation, and sharing without payment. But “personal use” is defined to exclude any sale for money, and paid advertising for mushroom-related services is treated as evidence of prohibited commercial activity. Licensing rules for cultivators, manufacturers, testers, and facilitators are still being developed by the state’s natural medicine division.
Clinical Trials
Outside Oregon and Colorado, the main legal pathway is FDA-authorized clinical research. The FDA has issued guidance for researchers developing psychedelic drugs, including psilocybin, for psychiatric and substance use disorders.5U.S. Food and Drug Administration. Psychedelic Drugs: Considerations for Clinical Investigations Ongoing trials are investigating psilocybin therapy for treatment-resistant depression, PTSD, and other conditions. Participation requires enrollment through the research institution, and all psilocybin use occurs under medical supervision.
Unlicensed Storefronts and Gifting Shops
Unlicensed psilocybin storefronts have opened in several cities, particularly where decriminalization has created a false sense of legality. These shops typically operate under a “gifting” model: you buy an overpriced sticker or piece of art and receive mushrooms as a “free gift.” This is where most buyers get into trouble.
Law enforcement has not been fooled. In Washington, D.C., joint operations between local police, the alcoholic beverage and cannabis administration, and the attorney general’s office produced closure orders against dozens of shops. Raids uncovered psilocybin along with cocaine, methamphetamine, and cannabis products testing positive for other narcotics. One closure led to the seizure of over six pounds of psilocybin products alongside cocaine, methamphetamine, a firearm, and cash. Operators were charged with distribution of a controlled substance.
The products themselves carry health risks on top of the legal ones. Unlike Oregon’s regulated program, where psilocybin undergoes lab testing for potency and contaminants, products from unlicensed shops have no quality controls. There is no way to verify what a product actually contains, what dose it delivers, or whether it has been contaminated. The regulated testing infrastructure that exists for legal cannabis and for Oregon’s psilocybin program does not exist for the black market.
If you are looking for legal psilocybin, the answer is a supervised session at a licensed Oregon service center, a Colorado healing center once that program is fully operational, or enrollment in an approved clinical trial. It is not a dispensary, and it is not a storefront.